Connect with us

Hi, what are you looking for?

World

‘Bad boy’ pharma chief mocks Australian student achievements

-

"Bad boy" pharmaceutical chief Martin Shkreli, who raised the cost of an HIV drug by 5,000 percent, has mocked a group of Sydney school students who recreated the life-saving medicine on the cheap.

The teenagers said they were spurred to try recreate the drug after Shkreli became a global figure of hate by buying the rights to Daraprim and then hiking the price in the United States from $13.50 a tablet to $750.

In response Shkreli tweeted some sarcastic remarks about the students' successful recreation of pyrimethamine, the active ingredient for Daraprim, an anti-parasitic used to treat people with low immune systems such as those with HIV.

"Labor and equipment costs? Didn't know you could get physical chemists to work for free?" Shkreli tweeted. "I should use high school kids to make my medicines!

"And why buy my equipment when I can use the lab's for free?! And those teachers who told them what to do, they'll work for free, right."

Student James Wood said this week he and his friends, with the help of University of Sydney chemists, had started off with just $20 of the drug, and in one reaction had produced thousands of dollars' worth.

Turing Pharmaceuticals, which Shkreli used to head, continue to sell the only FDA-approved form of the drug in the US, but reportedly cut the price in half for hospitals after an outcry.

Daraprim, which figures on the World Health Organisation list of essential medicines, is cheap in most countries, with 50 tablets selling in Australia for $10.

In another tweet about the students Shkreli said: "We know they made this, how? Cause they said so?"

Several hours after being blasted on Twitter for his comments, Shkreli was more gracious in a short YouTube clip Friday.

"These Australian students are proof that the 21st century economy will solve problems of human suffering through science and technology," he said.

"We should congratulate these students for their interest in chemistry and all be excited about what is to come in this stem-focused 21st century."

“Bad boy” pharmaceutical chief Martin Shkreli, who raised the cost of an HIV drug by 5,000 percent, has mocked a group of Sydney school students who recreated the life-saving medicine on the cheap.

The teenagers said they were spurred to try recreate the drug after Shkreli became a global figure of hate by buying the rights to Daraprim and then hiking the price in the United States from $13.50 a tablet to $750.

In response Shkreli tweeted some sarcastic remarks about the students’ successful recreation of pyrimethamine, the active ingredient for Daraprim, an anti-parasitic used to treat people with low immune systems such as those with HIV.

“Labor and equipment costs? Didn’t know you could get physical chemists to work for free?” Shkreli tweeted. “I should use high school kids to make my medicines!

“And why buy my equipment when I can use the lab’s for free?! And those teachers who told them what to do, they’ll work for free, right.”

Student James Wood said this week he and his friends, with the help of University of Sydney chemists, had started off with just $20 of the drug, and in one reaction had produced thousands of dollars’ worth.

Turing Pharmaceuticals, which Shkreli used to head, continue to sell the only FDA-approved form of the drug in the US, but reportedly cut the price in half for hospitals after an outcry.

Daraprim, which figures on the World Health Organisation list of essential medicines, is cheap in most countries, with 50 tablets selling in Australia for $10.

In another tweet about the students Shkreli said: “We know they made this, how? Cause they said so?”

Several hours after being blasted on Twitter for his comments, Shkreli was more gracious in a short YouTube clip Friday.

“These Australian students are proof that the 21st century economy will solve problems of human suffering through science and technology,” he said.

“We should congratulate these students for their interest in chemistry and all be excited about what is to come in this stem-focused 21st century.”

AFP
Written By

With 2,400 staff representing 100 different nationalities, AFP covers the world as a leading global news agency. AFP provides fast, comprehensive and verified coverage of the issues affecting our daily lives.

You may also like:

Business

The mindset of "trust none, verify all" is based on the zero-trust paradigm and is applied through identity authentication.

Tech & Science

15 percent of people aged 40-75 have a form of undiagnosed high blood pressure (or hypertension) that occurs only at night-time.

Business

100 percent of pay for 80 percent of the time. Sounds good?

Business

Go out and vote to protect your rights, top Italian designers urged compatriots this week as the Milan shows coincided with elections.